Strikingly, three out of five chronic lymphocytic leukemia (CLL) blood samples contained a large proportion of CD45+/CD19+/CD235a+ cells (Figures 4A, B; Supplementary Figure 12A). This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.